Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients. [electronic resource]
Producer: 20170523Description: 45-52 p. digitalISSN:- 1449-1907
- Adult
- Antiviral Agents -- therapeutic use
- Female
- Follow-Up Studies
- Hepatitis C, Chronic -- complications
- Humans
- Interferon-alpha -- therapeutic use
- Liver -- drug effects
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Multivariate Analysis
- Non-alcoholic Fatty Liver Disease -- etiology
- Polyethylene Glycols -- therapeutic use
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.